Difference between revisions of "Spebrutinib (CC-292)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Kinase inhibitors" to "") |
m |
||
| Line 6: | Line 6: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | + | [[Category:Oral medications]] | |
| − | |||
[[Category:BTK inhibitors]] | [[Category:BTK inhibitors]] | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
Latest revision as of 23:32, 23 February 2021
Mechanism of action
Bruton's tyrosine kinase (BTK) inhibitor
Also known as
- Code names: AVL-292, CC-292